Tumor treating fields for high-grade gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor treating fields for high-grade gliomas

Published:2020-07 Issue: Volume:127 Page:110193
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Luo Chengke,Xu Shengchao,Dai Gan,Xiao Zhiqiang,Chen Ling,Liu Zhixiong

Funder

Youth Program of National Natural Science Foundation of China

Youth Program of Natural Science Foundation of Hunan Province

Key Research and Development Program of Hunan Province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference40 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015;Ostrom;Neuro Oncol,2018

2. Immune checkpoint in glioblastoma: promising and challenging;Huang;Front Pharmacol,2017

3. Glioblastoma treatment modalities besides surgery;Zhang;J Cancer,2019

4. A novel prognostic signature of transcription factors for the prediction in patients with GBM;Cheng;Front Genet,2019

5. Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients;Chen;Ann Transl Med,2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma;Frontiers in Oncology;2024-03-20

2. Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence;Medicine;2023-12-01

3. Comparative dosimetric study of radiotherapy in high-grade gliomas based on the guidelines of EORTC and NRG-2019 target delineation;Frontiers in Oncology;2023-05-23

4. TTFields Prolonged the PFS of Epithelioid Glioblastoma Patient: A Case Report;Brain Sciences;2023-04-07

5. Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma;Pharmaceutics;2023-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3